Drug
Itopride clinical trials
Includes 5 studies of Itopride hydrochloride.
- studies test it
- 20
- open now
- 2
- in phase 3
- 10
- first study started
- 2000
Keep track of what changes. Save the itopride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2004 (4)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 7
- Phase 3
- 10
- Phase 4
- 2
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 11
Forest Laboratories (7) · Abbott (2) · Universitaire Ziekenhuizen KU Leuven (2) · Shanghai Jiao Tong University School of Medicine (1) · Inje University (1) · Mayo Clinic (1) · Royal Adelaide Hospital (1) · October 6 University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses itopride is read from its arms, and is right about nine times in ten.
Testing it · 20
- Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)Not yet recruitingPhase 2October 6 UniversityNCT05966025Written as Itopride
- Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial PeritonitisRecruitingPhase 3Tanta UniversityNCT04161768Written as Itopride
- Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional DyspepsiaCompletedPhase 3AbbottNCT06217393Written as Itopride Hydrochloride 150 mg extended release tablets
- Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at ColonoscopyStatus unknownNot applicableMahidol UniversityNCT04104867Written as Itopride
- Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS SubgroupCompletedPhase 4Universitaire Ziekenhuizen KU LeuvenNCT04647955Written as Itopride
- Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled TrialCompletedPhase 4Universitaire Ziekenhuizen KU LeuvenNCT04464369Written as itopride
- Itopride in Feeding Intolerance of Critically-ill Patients Receiving Enteral NutritionStatus unknownNot applicableAin Shams UniversityNCT03698292Written as Itopride
- Effects of Itopride on Gastric Motor and Sensory Functions in Healthy VolunteersCompletedPhase 1/2Forest LaboratoriesNCT00370110Written as Itopride 100 mg
- Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and GlycemiaCompletedPhase 1/2Forest LaboratoriesNCT00370084Written as Itopride
- Efficacy and Safety of Itopride vs Placebo in HeartburnCompletedPhase 3Forest LaboratoriesNCT00382577Written as Itopride
- Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional DyspepsiaCompletedPhase 3Forest LaboratoriesNCT00110968Written as Itopride hydrochloride
- Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional DyspepsiaCompletedPhase 3Forest LaboratoriesNCT00112203Written as Itopride
- Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a MealCompletedPhase 3Forest LaboratoriesNCT00112190Written as Itopride Hydrochloride
- Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a MealCompletedPhase 3Forest LaboratoriesNCT00112177Written as Itopride Hydrochloride
- Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant ConstipationCompletedPhase 2AbbottNCT01027260Written as Itopride HCI 50 mg
- Itopride as an Adjuvant for Bowel Preparation in Patients With Chronic Constipation is EffectiveCompletedPhase 2Shanghai Jiao Tong University School of MedicineNCT01513811Written as Itopride and Polyethylene glycol electrolyte solutions
- Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel PreparationCompletedPhase 3Inje UniversityNCT01513096Written as itopride
- A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.CompletedPhase 2/3Mayo ClinicNCT00308399Written as Itopride
- Effect Of Itopride On Gastric Emptying And Accommodation In Patients With Functional DyspepsiaStatus unknownNot applicableAga Khan UniversityNCT01226134Written as Itopride,
- Itopride in Functional Dyspepsia:a Dose Finding StudyCompletedPhase 2/3Royal Adelaide HospitalNCT00272103Written as Itopride (drug)
Given in every arm · 1 — itopride is usual care beside what is tested
As the comparator · 3 — what is tested is compared with itopride
- Comparing Acotiamide and Itopride for the Management of IndigestionNot yet recruitingPhase 4Aga Khan UniversityNCT07449689Written as itopride
- Helicobacter Pylori Eradication in Functional DyspepsiaCompletedNot applicableSir Ganga Ram HospitalNCT04697641Written as Itopride
- Randomized Controlled Trial of Acupuncture for Functional DyspepsiaCompletedNot applicableChengdu University of Traditional Chinese MedicineNCT00599677Written as Itopride
Codes
What other systems call itopride · ClinicalTrials.gg INT003940
- MeSH (NLM) C102254itoprideOne source NLM
- UNII (FDA) 81BMQ80QRLITOPRIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q4409774itoprideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65991ItoprideOne source FDA
- DrugBank DB04924One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C102254 | itopride | One source NLM |
| UNII (FDA) | 81BMQ80QRL | ITOPRIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4409774 | itopride | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65991 | Itopride | One source FDA |
| DrugBank | DB04924 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.